景業名邦(02231.HK)附屬就廣州住宅地進行聯合投資及開發
景業名邦(02231.HK)公布,間接全資附屬廣州意濃,與廣州金璨、目標公司及項目公司訂立投資合作協議,就土地進行聯合投資及開發。
目標公司註冊股本將由1,000萬元人民幣變更為2.75億元人民幣,其將由廣州金璨及廣州意濃分別按持股比例50%及50%注資。
目標公司持有一土地,位於中國廣州市增城區中新鎮新新公路東側,總土地面積約為25,989.93平方米。該土地旨在用於二類居住用地(R2)。二類居住用地(R2)指用於建造主要用作居住用途之多層建築物(具有全面配套設施)之國有土地,佔中國居住用地之主要部分。
廣州金璨由金地集團(600383.SH)最終全資擁有。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.